FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Aortic Valve, Prosthesis, Percutaneously Delivered

PMA: P140031 · Supplement: S170 · Decision Feb 14, 2024
Classifications
1
FEI Numbers
24
Registration Numbers
24

Basic Information

Device Name
Aortic Valve, Prosthesis, Percutaneously Delivered
Trade Name
Edwards SAPIEN 3 Transcatheter Heart Valve (THV), Edwards SAPIEN 3 Ultra THV, and Edwards SAPIAN 3 Ultra RESILIA THV
PMA Number
P140031
Supplement Number
S170
Device Class
FDA Class 3
Product Code
NPT
Generic Name
Aortic valve, prosthesis, percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
February 14, 2024
Date Received
January 18, 2024
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

to add alternative manufacturing sites for the frame components

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPT Aortic Valve, Prosthesis, Percutaneously Delivered